Podcasts about view dr

amazon ncaa programs portal kevin macleod nil transfer portal smrt name image and likeness amazon author order dr view dr

Play Episode Listen Later May 17, 2024 26:59

In Episode 20 NCAA Consultant Chuck Smrt provides an up-to-date account of where the NCAA stands as far as rules and regulations for the 2024 Transfer Portal and the Name, Image and Likeness (NIL) programs. This is a follow-up to Chuck's expert opinion on the 2023 version of these two programs he shared with us last summer. Chuck also shares some of his thoughts about where all this is headed for the NCAA and for college athletes and what it does for amateurism in the U.S.***************************************************************** Leave a Comment/Review at drjoebrickner@gmail.com* Order Dr. Brickner's books on Amazon or go to his website* View Dr. B's Amazon Author page Here* Theme music for podcasts by Kevin MacLeod****************************************************************

NBPAS: The Alternative to the ABIM MOC

director gold wellness medicine engagement wellbeing assistant professor campus outreach psychiatry washington university eye view quadcast jessi gold louis school view dr

Play Episode Listen Later Mar 26, 2024 64:00

Dr. Paul Teirstein, President of NBPAS.org, joins Chadi to highlight and reveal how the National Board of Physicians and Surgeons (NBPAS) is challenging the status quo of board certification for all medical practitioners. With a mission to advocate for physicians and combat the monopoly of Maintenance of Certification, Dr. Teirstein explains how NBPAS provides a refreshing alternative for continuous board certification. Visit the NBPAS website. https://nbpas.org/ View Dr. Teirstein debating Dr. Lois Margaret Nora of the American Board of Medical Specialties. https://www.youtube.com/watch?v=_fc3BQ-9yMM View Dr. Teirstein's MOC presentation. https://www.youtube.com/watch?v=h1vw2RPCd1s Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on YouTube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA

president physicians maintenance certification american board national board moc abim chadi view dr medical specialties teirstein

Ep. 67 A Bird's Eye View: Dr. Jessi Gold's Perspective on Whole-Campus Wellbeing

The Quadcast

Play Episode Listen Later Nov 29, 2023 26:11

Dr. Jessi Gold, Assistant Professor and the Director of Wellness, Engagement, and Outreach in the Department of Psychiatry at Washington University in St. Louis School of Medicine, joins the Quadcast to discuss campus-wide mental wellbeing. As a clinician who sees students, faculty and administrators, she has a unique perspective into the mental wellbeing of all campus stakeholders and how those populations interact with one another.

What is the TAPUR (Targeted Agent and Profiling Utilization Registry) Study, with Richard Schilsky, MD, FACP, FASCO

green dna fill cornell university apples tart spooktober agritech ologies emily white view dr nick thorburn

Play Episode Listen Later Nov 9, 2023 11:18

ASCO: You're listening to a podcast from Cancer.Net. This cancer information website is produced by the American Society of Clinical Oncology, known as ASCO, the voice of the world's oncology professionals. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guests' statements on this podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Cancer research discussed in this podcast is ongoing, so data described here may change as research progresses. ASCO's first clinical trial is the Targeted Agent and Profiling Utilization Registry, or TAPUR Study. This clinical trial is intended for people with advanced cancer without other treatment options available, and whose cancer has at least one genomic variation that can be targeted with specific drugs. In this podcast, Dr. Richard Schilsky discusses the TAPUR study and explains why it is significant. He also discusses what participants can expect. Dr. Schilsky is the Principal Investigator for the TAPUR study. He is also the former Chief Medical Officer for ASCO and Professor Emeritus at University of Chicago. View Dr. Schilsky's disclosures at Cancer.Net. Dr. Schilsky: Hi, everyone. My name is Richard Schilsky and I'm the principal investigator of the ASCO TAPUR Study and the former Chief Medical Officer of ASCO. I'm happy to give you an overview and update about the study today. By the way, TAPUR is an acronym that stands for Targeted Agent and Profiling Utilization Registry. Hopefully, the reason for naming it that will become clear as you listen. The TAPUR study was conceived in 2013 and launched in 2016, and was based on the observation that there was a rapid increase in testing the tumors of patients with advanced cancer for gene mutations that might be contributing to the growth of the tumor, so-called genomic profiling, in the hope of finding a genomic alteration that could potentially be treated by a drug that was already FDA-approved for a different tumor type than what the patient had. Meaning, in order for the patient to receive the drug, it would have to be prescribed off-label. The challenge with prescribing the off-label use of a drug is that most insurance plans don't cover the cost of treatment. Additionally, even if the patient were able to receive the drug, there was no mechanism for the oncology community to learn from the patient's treatment experience. The TAPUR study has managed to address these challenges by providing access to FDA-approved drugs at no cost to the patient and providing treatment results to the oncology community regarding the effects of off-label use of the treatments being studied. Now, TAPUR is a clinical trial, and its primary objective is to describe the anti-tumor activity and toxicity of commercially available targeted anti-cancer drugs prescribed for treatment of patients whose tumors have a genomic alteration known to be a drug target or to predict sensitivity to a drug. TAPUR was designed to be simple for providers and patients. It's a phase 2 study, meaning that we're aiming to learn about efficacy and safety. It's prospective, that is, it enrolls patients going forward. It is not randomized. Everybody gets a treatment based on the genomic profile of their tumor and the available treatments in the study. It's a multi-basket study. That is to say, multiple therapies are available on the study that are targeting multiple genomic alterations. And it's a pragmatic study. TAPUR attempts to replicate routine clinical care. It's exempt from FDA oversight. It provides oral drugs that can be shipped directly to the patient's home after the first visit. Now, as I said, the TAPUR study was launched in March of 2016. And as of this month, it's still going strong, with more than 2,700 patients having been enrolled at 267 locations in 28 states. So how does the study work? Well, a patient's physician has results of a genomic profile of the patient's tumor and determines that a study drug might benefit the patient. The patient then decides to participate in TAPUR and gives their informed consent. A molecular tumor board, which is a group of experts convened by ASCO, is available to consult regarding the proposed treatment or to provide alternative treatment options for the patient. A participating pharmaceutical company, and there are 10 right now, provides the study treatments at no cost to the patient. The patient is cared for by their own oncologist, receives a standard dose of the drug, and is evaluated at standard intervals to see if the treatment is working and if they're having any side effects. ASCO has convened an independent data and safety monitoring board of cancer experts that periodically reviews results and determines whether treatment is promising for a particular cancer type and genomic alteration. That's what we call a cohort in the study. Once the data are finalized, ASCO publishes the study findings in peer-reviewed journals to inform clinical practice and future research. So let me give you an example. There are specific molecular alterations that often appear in tumor cells that are important for driving the growth and progression of the cancer and can be targeted with specific drugs that interrupt those abnormal molecular pathways. Many of these alterations occur at low frequency, meaning in less than 5% of tumors of any given type. The benefit of the TAPUR trial having a basket design is our ability to evaluate multiple therapies simultaneously to target multiple low-frequency alterations, which ultimately offers more treatment options to patients who wish to participate in the study. If the TAPUR study were set up looking to target only a single genomic alteration, we would potentially have to screen hundreds of patients in order to find one who is appropriate for the trial, which also means hundreds more would still be left without treatment options. But because TAPUR evaluates multiple treatments and multiple genomic alterations simultaneously, we found that about two-thirds of patients who were screened for the trial ultimately enroll. A specific example of a drug and targeted gene alteration on TAPUR is the use of the treatment combination pertuzumab plus trastuzumab in tumors with ErbB2 amplification or mutation. Now, you may be aware that ErbB2 is a gene that is synonymous with the HER2 gene that is frequently amplified or overexpressed in patients with breast cancer. And this drug combination, pertuzumab and trastuzumab, is FDA-approved for treatment of patients with breast cancer. But in the TAPUR study, we found multiple tumor types outside the FDA-approved label that can benefit from this treatment if an ErbB2 alteration is detected, including patients with colorectal cancer, endometrial [uterine] cancer, biliary tract cancer, and lung cancer. To learn more about TAPUR, please follow our progress at the ASCO website. In an effort to provide up-to-date information about cohorts that are available for enrollment on the TAPUR study, ASCO launched a public-facing status report in March of 2023. So first click on www.tapur.org. Click on the link to the ASCO website. From there, select study participation at the bottom of the page. Once at the study participation page, click on the link to see a list of study cohorts that are currently enrolling. The report updates daily, providing viewers with an up-to-date list of available study cohorts based on their genomic alterations. It's important to note that study cohorts are available on a first-to-enroll basis. You can also find information about current results from the TAPUR study on the study results page. So what have we learned so far? Thus far, we've publicly reported results on 29 cohorts of patients. 17 gave a positive signal of treatment activity, 12 were negative. Now we feel it's just as important to report on the negative results as the positive results. If the treatment is unlikely to be effective for patients, it's important to inform the oncology community because all of the drugs in the study are commercially available and could be prescribed to a patient. Enrollment to patients on TAPUR is very representative of the U.S. population. The study has broad eligibility criteria that allows more patients to enroll, including patients with an ECOG performance status of 0 to 2 and younger patients. Some treatments allow for adolescent patients as young as age 12 to be enrolled in the study. We hope the oncology community finds value in the TAPUR study. Physicians have the opportunity to contribute to research and participate in publications and to contribute more knowledge in the field of oncology. TAPUR provides guidance on interpreting genomic reports via the molecular tumor board and provides additional treatment options for patients. Institutions obtain insights on potential new uses of existing drugs and their side effects, and TAPUR data can inform updates to clinical practice guidelines. And patients receive access to drugs not available as standard of care. Patients may be able to receive oral drugs at their home and limit their commute to clinic. And of course, participation in the study provides an opportunity for patients themselves to contribute to knowledge about cancer treatments. To find a clinical site offering the TAPUR study, please visit the TAPUR website again, www.tapur.org and select “Participating Centers.” This will lead to a searchable map of participating sites and includes the site-specific contacts. Contact the primary contact listed for that site. Thank you for listening to this update on the ASCO TAPUR study and enjoy the rest of your day. ASCO: Thank you, Dr. Schilsky. Learn more about clinical trials, including the TAPUR Study, at www.cancer.net/clinicaltrials. Cancer.Net Podcasts feature trusted, timely, and compassionate information for people with cancer, survivors, and their families and loved ones. Subscribe wherever you listen to podcasts for expert information and tips on coping with cancer, recaps of the latest research advances, and thoughtful discussions on cancer care. And check out other ASCO Podcasts to hear the latest interviews and insights from thought leaders, innovators, experts, and pioneers in oncology. Cancer.Net is supported by Conquer Cancer, the ASCO Foundation, which funds lifesaving research for every type of cancer, helping people with cancer everywhere. To help fund Cancer.Net and programs like it, donate at CONQUER.ORG/Donate.

Pomology (APPLES) with Susan K. Brown

Ologies with Alie Ward

Play Episode Listen Later Oct 18, 2023 91:01

Green, yellow, striped, red, shiny, russet. Tart, sweet, sour, crunchy. Big, small, wild, heirloom, cultivated. How will you like them apples? Very much, once you hear all about the fascinating backstory of how an apple got into your lunch with one of the world's finest pomologists and geneticists, the incredibly knowledgeable and charming Dr. Susan K. Brown, a professor at Cornell University's AgriTech division. Fill your baskets with apple picking tips, genetic mash ups, taste test requirements, DNA trivia, compost treasures, maggot babies, the animal dung that changed history, how to have your own orchard, the sweet taste of science redemption, the loudest apple crunch on record, and what you're actually tasting when you enjoy this feat of breeding. You'll forever appreciate this everyday fruit. View Dr. Susan K. Brown's publications on ResearchGateVisit websites for apples developed by Dr. Brown: RubyFrost and SnapDragonThe Apple Lover's CookbookA charity will be linked soonMore episode sources and linksSmologies (short, classroom-safe) episodesOther episodes you may enjoy: SPOOKTOBER episodes, Ciderology (DELICIOUS APPLE BEVERAGES), Cucurbitology (PUMPKINS), Dendrology (TREES), Gustology (TASTE), Benthopelagic Nematology (DEEP SEA WORMS), Food Anthropology (FEASTS), Indigenous Cuisinology (NATIVE FOODS), Black American Magirology (FOOD, RACE & CULTURE)Sponsors of OlogiesTranscripts and bleeped episodesBecome a patron of Ologies for as little as a buck a monthOlogiesMerch.com has hats, shirts, stickers, totes!Follow @Ologies on Twitter and InstagramFollow @AlieWard on Twitter and InstagramEditing by Mercedes Maitland of Maitland Audio ProductionsTranscripts by Emily White of The WordaryWebsite by Kelly R. DwyerTheme song by Nick Thorburn

What is Pediatric Palliative and Supportive Care, with Abby Rosenberg, MD, MS, MA

cancer hospitals massachusetts conquer american society hospice pediatric rosenberg boston children palliative asco dana farber cancer institute clinical oncology supportive care conquer cancer view dr net podcasts

Play Episode Listen Later Oct 5, 2023 9:54

ASCO: You're listening to a podcast from Cancer.Net. This cancer information website is produced by the American Society of Clinical Oncology, known as ASCO, the voice of the world's oncology professionals. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guests' statements on this podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Cancer research discussed in this podcast is ongoing, so data described here may change as research progresses. In this podcast, Dr. Abby Rosenberg discusses what parents and family members of children with cancer should know about palliative and supportive care. She addresses the way palliative and supportive care is different from hospice or end-of-life care, what to expect when meeting with the palliative and supportive care team, and the ways this type of care can support children with cancer and their families. Dr. Rosenberg is the chief of pediatric palliative care at the Dana-Farber Cancer Institute and Boston Children's Hospital in Boston, Massachusetts. View Dr. Rosenberg's disclosures at Cancer.Net. Dr. Rosenberg: Hi, my name is Abby Rosenberg. I am the chief of pediatric palliative care at the Dana-Farber Cancer Institute and Boston Children's Hospital. And today we're going to be talking about what pediatric palliative care is, maybe demystifying it a little bit, and more importantly, talking about how it can help kids with cancer and their families. I think one of the most important things to know about palliative care is that it is a specialized kind of medical care for people who live with serious illnesses like cancer. And folks who are receiving palliative care are receiving extra support to help them with complicated symptoms, pain, distress, as well as complicated decisions that they might need to make in the process of their illness. Palliative care is really intended to help enhance a person's current care by focusing on their quality of life, and not only the patient's quality of life but also the quality of life for the whole family. In pediatrics, that includes parents, siblings, and other kids who might be members of the community. The way I think about palliative care is that it is really intended to help people live their best lives for as long as possible. And so with that in mind, it can really help a whole bunch of people who are affected by pediatric cancer. And the way we do that is by delivering help through what we call an “interprofessional team.” And so a palliative care team in pediatrics includes physicians, it includes nurses, includes advanced practice providers like nurse practitioners, it includes social workers. It may also include child life specialists, psychologists, chaplains, other folks who are involved in the child's overall well-being. Palliative care can be provided at any time in a child's cancer experience and anywhere. It can be delivered while you are in the clinic, while you are in the hospital staying overnight, and we can deliver it to you at home. Some people confuse palliative care and hospice care, and those are 2 different things. So palliative care can be delivered concurrently with cancer-directed and cure-directed therapy. And generally, when we talk about hospice, it is for patients and families who have started to understand and recognize that perhaps their cancer might not be curable, and they are making the courageous and loving decision to switch gears and focus more on quality of life without continuing cure-directed therapies. Hospice care, like palliative care, can be delivered in a bunch of different settings. And most times in pediatric hospice care, we think about delivering it to a child in their home and within their home community. Some of the things that parents often ask us when we're talking about palliative care for their kids with cancer is, how do I know if my child is ready? And how do I ask for it? The answer to the first question is that again, your child can be ready for palliative care at any time. And it's really intended to help you navigate the heart of having a child with cancer. And that can, again, include anything from making complicated decisions, processing complicated information, making plans for you and your child's future, and managing complex pain and symptoms. How you ask for it is in most pediatric cancer centers, there is an embedded palliative care team that can help you. So you can ask any of your doctors and nurses and other folks who are taking care of you and your family. The last thing I'll say about palliative care is that it is a subspecialty team of experts who are good at all of these things like communication and pain and symptom management. Most pediatric oncologists do what we call primary palliative care, and that is they help support you in all of these things, too. So they help talk to you about complicated decisions and upcoming plans. They help talk to you about what might be coming with your child's symptoms, and they really help you navigate the cancer experience. And so what we try to do in pediatric palliative care is partner with you and your oncology team so that we just become a bigger team, thinking more holistically about all of the ways we can support you and your family. I think, in the end, the message of all of this is that every person taking care of a kid with cancer is trying to help that kid to thrive. And pediatric palliative care can be a really important resource to help kids to do that to the best of their abilities. So another question that we can hear from parents and families is what to expect when the palliative care team gets called. I think at a minimum, the expectation is that you will meet more people who will be really curious about your family and your child. They will ask a lot of questions about what matters to you, what are your values. They'll ask you questions about what is happening with the child's illness, what are your worries, what are your hopes, and what they do with all of that information is they help you process it, and they help translate it into something that can work for your child's overall cancer care. Part of meeting a palliative care team is always meeting all of these different members of the team, so you'll meet doctors, nurses, nurse practitioners, social workers, perhaps chaplains, child life specialists, psychologists, all of the folks that I previously mentioned. And the reason we have those big teams is because we recognize that each member of that team can help you with a different part of your whole cancer experience. And so for example, if your faith and your spiritual community is a really big part of how you are coping with being the parent of a child with cancer. We want to connect you with that part of your own strengths and resources and figure out how to support you while you are under our care in the hospital setting. So one other thing that pediatric palliative care teams can help with is talking within your family. So sometimes we get questions about how do I talk to my child about what's happening, or how do I talk to my child's brothers and sisters about what's happening? Maybe it's a, how do I support their brothers and sisters? It could be about the challenges of being a parent with one kid in the hospital and others at home, and how do you maintain your identity as a parent? How do you still be a good parent to a large family when you have one child who's really sick with cancer? And we in palliative care really can help you with that with all of the different resources and team members that I mentioned, and we can help you talk to your other kids. We can help your kids talk to each other. We can help you think as a parent about how you can navigate the situation that no parent could ever have planned for until they're in it. The other thing that we do within palliative care and the other thing you can expect is we partner very closely with your oncology team, not to replace them or make decisions on their behalf, but more to help them know you better. And so what we do is we talk together about what we are hearing from you, about what your child might need. We provide advice, we provide recommendations, for example, for how to manage perhaps complicated symptoms. We might have conversations with you and your oncologist together in the room to think as a bigger team about how we can support your child's well-being. And we'll often ask you questions in the midst of all of this about what you think is important for your child, how you want to spend your time, how you define your child's quality of life, and how we, as a larger program, taking care of children with cancer, can do better to make sure your kid is thriving for as long as possible. ASCO: Thank you, Dr. Rosenberg. Learn more about palliative and supportive care at www.cancer.net/palliative. Cancer.Net Podcasts feature trusted, timely, and compassionate information for people with cancer, survivors, and their families and loved ones. Subscribe wherever you listen to podcasts for expert information and tips on coping with cancer, recaps of the latest research advances, and thoughtful discussions on cancer care. And check out other ASCO Podcasts to hear the latest interviews and insights from thought leaders, innovators, experts, and pioneers in oncology. Cancer.Net is supported by Conquer Cancer, the ASCO Foundation, which funds lifesaving research for every type of cancer, helping people with cancer everywhere. To help fund Cancer.Net and programs like it, donate at CONQUER.ORG/Donate.

Exclusive Dr. Hyman+ Functional Medicine Deep Dive: Stress And Supplements

The Doctor's Farmacy with Mark Hyman, M.D.

Play Episode Listen Later Oct 3, 2023 64:50

Hey podcast community, Dr. Mark here. My team and I are so excited to offer you a 7 Day Free trial of the Dr. Hyman+ subscription for Apple Podcast. For 7 days, you get access to all this and more entirely for free! It's so easy to sign up. Just go click the Try Free button on the Doctor's Farmacy Podcast page in Apple Podcast. In this episode, you'll hear our latest Dr. Hyman+ Functional Medicine Deep Dive on stress and supplements with Dr. Melinda Ring. Dr. Ring takes us on a journey to show us how our body responds to stress, what it can do naturally, and the circumstances where it may need additional support while responding to stress. She shares the environmental and lifestyle factors that can disrupt our internal stress monitor and the symptoms that can result from stress overload.Access Dr. Ring's Deep Dive Slides here. View Dr. Ring's Ted Talk here. Follow Dr. Ring on Instagram @drmelindaring. To learn more about the Institute of Functional Medicine, sign up for IFM's newsletter: https://www.ifm.org/about/free-newsletter/.With your 7 day free trial to Apple Podcast, you'll gain access to audio versions of:- Ad-Free Doctor's Farmacy Podcast episodes- Exclusive monthly Functional Medicine Deep Dives- Monthly Ask Mark Anything Episodes - Bonus audio content exclusive to Dr. Hyman+Trying to decide if the Dr. Hyman+ subscription for Apple Podcast is right for you? Email my team at plus@drhyman.com with any questions you have. Please note, Dr. Hyman+ subscription for Apple Podcast only includes Dr. Hyman+ in audio content. Hosted on Acast. See acast.com/privacy for more information.

stress doctors institute ring deep dive exclusive apple podcast acast ted talks supplements functional medicine hyman ifm day free view dr access dr

Are There Real Solutions to the ABIM MOC?

patients mount kilimanjaro view dr

Play Episode Listen Later Sep 26, 2023 63:35

Join Chadi in a thought-provoking discussion with Bryan Carmody, aka the “Sheriff of Sodium” and a pediatric nephrologist, as they tackle the challenges of the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Bryan shares his visionary solutions to simplify and improve the MOC process, shedding light on the potential benefits for physicians and patients alike. Whether you're a physician, healthcare professional, or just curious about the future of medical certification, this episode offers insights into a critical issue in modern medicine. View Dr. Carmody's YouTube discussions on the matter. https://www.youtube.com/watch?v=aNgf6oYZlcg https://www.youtube.com/watch?v=2SsU2Y40XwY View “The Sheriff of Sodium” blog. https://thesheriffofsodium.com/page/6/ Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on Youtube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA

sheriffs american board sodium moc real solutions carmody abim chadi view dr certification moc

#7: What Every Patient Should Know

The Hoeflinger Podcast

Play Episode Listen Later Sep 16, 2023 33:16 Transcription Available

In this episode, Dr. Hoeflinger provides invaluable insights into the entire patient healthcare journey, from the initial medical office visit to post-surgical recovery and follow-up. He offers a transparent and compassionate look at the patient journey from the perspective of a surgeon. This episode serves as an indispensable guide for patients, demystifying the complex healthcare process and empowering individuals to navigate their medical journeys with confidence.Click Here to View Dr. Hoeflinger's Patient Education VideosTune in every week for new episodes of The Hoeflinger Podcast with Dr. Brian Hoeflinger and Kevin Hoeflinger.Our Mount Kilimanjaro GoFundMe PageClick here to learn more about our trip and fundraising missionOur apparel: (Part of all proceeds go towards our Mt Kilimanjaro project fundraiser and BrianMatters, our nonprofit)Click here for Doctor Hoeflinger Store Dr. Brian Hoeflinger's BookThe Night He Died: The Harsh Reality of Teenage DrinkingDr. Brian Hoeflinger's linksClick here for all links for Dr. HoeflingerKevin Hoeflinger's linksClick here for all links for Kevin HoeflingerContact Us brian.hoeflinger1@gmail.com

Point of View August 28, 2023 : Bianca Davis, Rabbi Vladimir Pikman

Point of View Radio Talk Show

Play Episode Listen Later Aug 28, 2023 89:23

Monday, August 28, 2023 Welcome to Monday! Today on Point of View Dr. Merrill (Buddy) Matthews hosts. He welcomes Bianca Davis from New Friends New Life to talk about the scourge of sex-trafficking. In the second hour, Buddy speaks with Rabbi Vladimir Pikman who joins him in the studio to discuss religious persecution in Ukraine. […]

family freedom politics news religion ukraine buddy rabbi point of view pate marlin kerby view dr pikman maddoux

The Case Against the ABIM MOC With Wes Fisher

america university medicine associate professor evanston moc abim chadi chicago pritzker school northshore university healthsystem view dr practicing physicians

Play Episode Listen Later Aug 15, 2023 83:50

Dr. Wes Fisher joins the show to continue highlighting ABIM recertification and the MOC program following a petition that has gathered over 12,000 signatures to end this program. Dr. Fisher is a clinical cardiac electrophysiologist at NorthShore University HealthSystem in Evanston, IL; he is also a clinical Associate Professor at the University of Chicago Pritzker School of Medicine. Dr. Fisher is triple board-certified in Internal Medicine (Grandfathered per the ABIM), cardiology, and cardiac electrophysiology. He is due for his FOURTH re-certification in cardiology after 12/31/2023 and FOURTH re-certification in EP after 12/31/2023. The process of re-certification and MOC became a core center in Dr. Fisher's advocacy on behalf of the physicians. He co-founded Practicing Physicians of America to advocate and educate and has done significant investigative work on the ABIM; you can see much of his writing on his blog as well as many other outlets. Why does a respected EP physician, with over 3 decades of experience and thousands of patients seen, need to do this re-certification again and pay yearly dues? Please listen to this exclusive revealing podcast and share with your colleagues. This is another ABIM-related MUST LISTEN podcast. Read more about Practicing Physicians of America. https://practicingphysician.org/join/ View Dr. Fisher's blog. https://drwes.blogspot.com/ Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on Youtube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA

Point of View August 8, 2023 : Dr. Bob Cornuke, Carol Roth

Point of View Radio Talk Show

Play Episode Listen Later Aug 8, 2023 89:20

Tuesday, August 8, 2023 Today on Point of View Dr. Merrill (Buddy) Matthews hosts. He welcomes Dr. Bob Cornuke, a biblical investigator, international explorer, and author of eleven books, to talk about his book Temple: Amazing New Discoveries that Change Everything About the Location of Solomon's Temple. In the second hour, Buddy speaks with the dynamic […]

family freedom politics news religion temple location buddy point of view pate marlin kerby carol roth view dr bob cornuke maddoux

#068 (Aug. 10, 2022) Hyperbaric Oxygen in Post-Vaccine and Long Haul Treatment: FLCCC Weekly Update

FLCCC Alliance

Play Episode Listen Later Jul 9, 2023 83:25

#068 (Aug. 10, 2022) Hyperbaric Oxygen in Post-Vaccine and Long Haul Treatment: FLCCC Weekly Update Joyce Kamen hosted the weekly update this week discussing the use of Hyperbaric Oxygen in treating long-haul and post-vaccine injury. Dr. Kory and Dr. Marik welcomed Dr. Paul Harch, Dr. Ted Fogarty, and Dr. Bradley Meyer where the discussion ranged from the possibility of measuring blood gas levels at the capillary level, to how Argon protects mitochondria, to the prices of soft and hard shell hyperbaric chambers, and the average fees for the HBOT treatments, and much more. View Dr. Paul Harch's 'Hyperbaric Oxygen Therapy and COVID-19: Acute Infection, Long-Hauler's Syndrome, and Vaccine Injury' slides here:https://covid19criticalcare.com/wp-content/uploads/2022/08/FLCCC-Webinar8-10-2022HBOT-COVID-Hertz-Infection-Long-Haulers-Vaccine-Injury.pdf Formed by leading critical care specialists in March 2020, the Front Line COVID-19 Critical Care Alliance (FLCCC) has developed highly effective treatment protocols that aim to prevent and treat COVID-19 at all stages of the disease. We are a 100% donor-supported 501(c)(3) non-profit organization — our work would not be possible without you.Your gifts help us expand our reach and share the latest research available, for the health and well-being of all. To donate online, click here: https://covid19criticalcare.com/network-support/support-our-work/ To follow FLCCC, click here: https://covid19criticalcare.com/follow-flccc-2/ To learn more about our protocols click here https://covid19criticalcare.com/covid-19-protocols/ To register for weekly webinars, click here: https://geni.us/FLCCC_Webinar_Register To buy FLCCC gear, click here: https://supportflccc.store/ --------------------------------- covid long haulflccc webinarhyperbaric oxygenpost vaccine injury

covid-19 vaccines treatments syndrome long haul kory weekly update hyperbaric oxygen therapy hbot argon vaccine injury hyperbaric oxygen marik front line covid flccc view dr critical care alliance flccc

Replay - EBB 155 - Pelvic Floor Health in Pregnancy and Postpartum with Dr. Juan Michelle Martin

Evidence Based Birth®

Play Episode Listen Later May 17, 2023 32:08

May 17, 2023 - On today's episode we are honoring Pelvic Floor Awareness Month with a replay episode from one of our most popular episodes, an interview with Dr. Juan Michelle Martin all about pelvic floor health in both pregnancy and postpartum. Content warning: discussion of sexual function and dysfunctions in plain terms. In this episode, I will be talking with Dr. Juan Michelle Martin. Dr. Martin is a pelvic floor specialist for 13 years and now an Evidence Based Birth® Instructor. Dr. Martin is the owner and founder of JMM Health Solutions. She's created a few programs for pregnant individuals as well as two coaching programs, one of them being a 12-week program for people with endometriosis, and the other being a four-week program for individuals suffering from dyspareunia. We talk about the benefits of pelvic floor therapy for pregnancy and postpartum. We also talk about the importance of advocating for accessible pelvic care services. Learn more about Dr. Juan Michelle Martin here (https://www.jmmhealthsolutions.com/). Follow Dr. Martin on Instagram here (www.instagram.com/thepelvicperspective). View Dr. Martin's pelvic floor topic videos on YouTube for JMM Health Solutions here (https://www.youtube.com/channel/UCKNEkVefn_wLgrqlf4wyXHw). Learn more about Academy of Pelvic Health (APH) here (https://aptapelvichealth.org/). Follow APH on Facebook here (https://www.facebook.com/aptapelvic/). Learn more about Herman & Wallace here (https://hermanwallace.com/). Follow Herman & Wallace on Facebook here (https://www.facebook.com/HermanandWallace/). Listen to recent EBB episodes about Pelvic Floor Health & Postpartum: EBB 256 - Top 3 Recommendations for Preventing Pelvic Floor Dysfunction after Birth with Dr. Sarah Duvall EBB 264 - Top 3 Tips for Exercise in Pregnancy with Mamastefit For more information and news about Evidence Based Birth®, visit www.ebbirth.com. Find us on Facebook (https://www.facebook.com/EvidenceBasedBirth/), Instagram (https://www.instagram.com/ebbirth/), and Pinterest (https://www.pinterest.com/ebbirth/). Ready to get involved? Check out our Professional membership (including scholarship options) (https://evidencebasedbirth.com/become-pro-member/). Find an EBB Instructor here (https://evidencebasedbirth.com/find-an-instructor-parents/), Click here (https://evidencebasedbirth.com/childbirth-class/) to learn more about the Evidence Based Birth® Childbirth Class.

tips professional birth academy exercise pregnancy pinterest recommendations postpartum ebb pelvic floor health evidence based birth michelle martin view dr herman wallace evidence based birth instructor

Episode 19 - Ruth Murray: Brain & Body Connections (Part 3)

amazon interview body brain connections kevin macleod hierarchy physiology maslow amazon author brain gym order dr view dr

Play Episode Listen Later Apr 18, 2023 31:15

In the third and final episode of Ruth Murray's Interview on how we can help make our brain and body work better together, Ruth introduces us to her Developmental Pyramid. She uses the three sided structure to relate Maslow's Hierarchy of Needs with the Physiology of the Brain and the Developmental Nervous System. She then demonstrates some brain or body exercises (hacks) that help relieve specific issues like not being able to sleep, lightheadedness and constipation/diarrhea, among other items.***************************************************************** Leave a Comment/Review at drjoebrickner@gmail.com* Order Dr. Brickner's books on Amazon or go to his website* View Dr. B's Amazon Author page Here* Theme music for podcasts by Kevin MacLeod****************************************************************

Episode 19 - Ruth Murray: Brain & Body Connections (Part 2)

amazon body brain connections kevin macleod amazon author brain gym order dr view dr

Play Episode Listen Later Apr 18, 2023 23:58

Ruth builds on Part 1's concepts by providing examples of clients who were helped using Brain Gym and/or Rhythmic Movement exercises. She provides individual examples of parent/child relationships to athletic team performance success stories. Ruth also demonstrates some of the respective exercises from Brain Gym and Rhythmic Movement Training.***************************************************************** Leave a Comment/Review at drjoebrickner@gmail.com* Order Dr. Brickner's books on Amazon or go to his website* View Dr. B's Amazon Author page Here* Theme music for podcasts by Kevin MacLeod****************************************************************

Episode 19: Ruth Murray - Brain & Body Connections (Part 1)

amazon body brain connections kevin macleod registered nurses amazon author brain gym order dr view dr

Play Episode Listen Later Apr 3, 2023 31:47

Ruth Murray is a Registered Nurse who branched out to holistic, scientific methods of working with patients who struggle with symptoms that are a result of their subconscious nervous system not being fully connected. This brain/body connection ranges from treating anxiety and emotional control to balance and sleep issues.In Part 1 of "Body & Brain", Ruth tells how her success using these methods with her children resulted in her creating her own practice to deal with brain/body issues of her clients. She describes Brain Gym® and Rhythmic Movement Training and provides examples of Brain Gym® techniques you can use to help someone read better, focus better, and control anger. She also provides actual examples of people she has helped overcome issues that dealt with a lack of brain and body connection.***************************************************************** Leave a Comment/Review at drjoebrickner@gmail.com* Order Dr. Brickner's books on Amazon or go to his website* View Dr. B's Amazon Author page Here* Theme music for podcasts by Kevin MacLeod****************************************************************

Mind Your Mood: What Are Your Moods Hatching?

Taking It On with Paula Price

Play Episode Listen Later Mar 23, 2023 17:05

SOUL OF SUCCESS SERIES Notable Quotes from Today's Podcast Your Soul is potent. It is the invisible you that makes the visible you successful or enslaved in this world. Your soul is an early voyager traveling the planet. What happened when God brooded over the water in Genesis? How is it connected to moodiness? Mind your moods. Answers and solutions give you the power to correct. You must give your will something to do. Key Scriptures Ezekiel 18:4 "Behold, all souls are mine; as the soul of the father, so also the soul of the son is mine: the soul that sinneth, it shall die." Isaiah 57:16 For I will not contend forever, Nor will I always be angry; For the spirit would fail before Me, And the souls which I have made. Job 34:10-12 “Therefore listen to me, you men of understanding: Far be it from God to do wickedness, And from the Almighty to commit iniquity. 11 For He repays man according to his work, And makes man to find a reward according to his way. 12 Surely God will never do wickedly, Nor will the Almighty pervert justice. Learn more about Dr. Price at www.drpaulaaprice.com Click Here to View Dr. Price's Soul of Success Classes

god soul mind price behold almighty moods hatching surely god view dr

Your Talent Can Take You Where Your Soul Can't Keep You

Taking It On with Paula Price

Play Episode Listen Later Mar 17, 2023 24:29

SOUL OF SUCCESS SERIES Your will is what will make or break you. And the degree to which you love and lust after your will is how free or enslaved you will be. Did you know the soul makes the difference between access and success? Here is Additional Food-for-Thought When you get in front of great people, they look for greatness (not just talent or passion). Great people want to stay great. Your talent can shine like new money, but it doesn't mean it can withstand the pressure of success. Your resume does not mean that you will be what you sold. Resumes are like portraits. You portray what you think about yourself. Not all dreams are prophetic. If you live by your wants, you will constantly sabotage your life. Click Here to View Dr. Price's Soul of Success Classes

soul price talent resumes view dr

Planning Your Perfect Ending | A Qur'anic View - Dr. Omar Suleiman

Digital Islamic Reminder

Play Episode Listen Later Mar 15, 2023 39:08

Planning Your Perfect Ending | A Qur'anic View - Dr. Omar Suleiman

planning ending omar suleiman view dr

Missing Pieces: A Room With A View (Dr. Chris Bonts)

First Baptist Middleburg Audio Sermon

Play Episode Listen Later Mar 12, 2023 35:16

missing pieces room with a view view dr

26: Building a Blissful Brain with Dawson Church, Ph. D.

Conscious Fertility

Play Episode Listen Later Feb 21, 2023 72:37

Can our thoughts and feelings impact our physical well-being? That's the question we're setting out to answer this week on the Conscious Fertility podcast. I'm joined by Dawson Church Ph.D., the founder of the National Institute for Integrative Healthcare, to talk with me about the incredible link our mindset has to our mental, emotional, and physical well-being — and the impact it could have on our fertility. In previous episodes, we've talked a lot about EFT, or the Emotional Freedom Technique, and how quickly it can rewire our brains to heal past trauma. In this episode, Dawson Church will share how EFT and having a positive mindset have led to positive fertility outcomes for couples struggling to conceive, helped people heal from PTSD, and taught others to turn adversity into conscious growth. If you're ready to build a more blissful brain and experience more joy — whether you're on a fertility journey or not — join us as we explore the fascinating abilities of our minds! Key Topics/Takeaways: Can our thoughts and feelings impact our physical well-being? [3:03] The correlation between negative thinking and Alzheimer's.. [5:43] Chronic stress as a barrier to fertility. [8:49] Fertility trauma, PTSD, and post-traumatic growth. [13:46] Cleaning up your act before entering parenthood. [19:13] Using adversity for conscious growth. [28:49] Emotional contagion. [35:11] Using EFT to dial our genes up or down. [38:46] Psychological and hormonal setpoints to experience more joy. [46:40] Building a blissful brain for a dramatically better life. [51:55] The link between DHEA and lowered cortisol. [55:05] Finding happiness regardless of how things are [58:09] Other Episodes on EFT and Fertility: Episode 21 - Loyd Auerbach https://open.spotify.com/episode/74L4HmLXplHd0fmGkjh90m?si=CLp373EcT26sIijB2LidxQ Episode 11 - Peta Stapletom https://open.spotify.com/episode/74L4HmLXplHd0fmGkjh90m?si=CLp373EcT26sIijB2LidxQ About Dawson Church: Dawson Church, Ph.D., is an award-winning science writer with three best-selling books to his credit. He has conducted dozens of clinical trials and founded the National Institute for Integrative Healthcare to study and implement promising evidence- based psychological and medical techniques. Its largest program, the Veterans Stress Project, has offered free treatment to over 20,000 veterans with PTSD over the past decade. His groundbreaking research has been published in many prestigious scientific journals. Dr. Church is the editor of Energy Psychology: Theory, Research, & Treatment, a peer-reviewed professional journal. He shares how to apply these breakthroughs to health and athletic performance through EFTUniverse.com, one of the most-visited alternative healing sites on the web. Where to Find Dr. Dawson Chruch: Free Ecomeditation: https://eftuniverse.com/ecomeditation/ Free EFT manual: https://eftuniverse.com/get-your-free-gifts/ Download the My Stress Solution App: https://mystresssolution.com/ Buy Dawson's Books: https://www.amazon.com/stores/Dawson-Church/author/B001JPCMZ6?ref=ap_rdr&store_ref=ap_rdr&isDramIntegrated=true&shoppingPortalEnabled=true View Dr. Church's full Curriculum Vitae and list of scientific papers: https://eftuniverse.com/about/dawson-church-vitae/ https://eftuniverse.com/research-studies/reprinted-academic-articles/ How to connect to Lorne Brown online and in person (Vancouver, BC): Acubalance.ca Conscious hacks and tools to optimize your fertility by Dr. Lorne Brown: https://acubalance.ca/conscious-work/ Download a free copy of the Acubalance Fertility Diet & Recipes from Acubalance.ca Connect with Lorne and the podcast on Instagram: @acubalancewellnesscentre @conscious_fertility_podcast @lorne_brown_official DISCLAIMER: By listening to this podcast, you agree not to use it as medical advice to treat any medical condition in either yourself or others. This podcast offers information to help the listener cooperate with physicians, mental health professionals or other healthcare providers in a mutual quest for optimal well-being. We advise listeners to carefully review and understand the ideas presented, and to consult your own physician for any medical issues that you may be having. Under no circumstances shall Acubalance, any guests or contributors to the Conscious Fertility podcast, or any employees, associates, or affiliates of Acubalance be responsible for damages arising from the use of the podcast.

Research Highlights from the 2022 San Antonio Breast Cancer Symposium, with Norah Lynn Henry, MD, PhD, FASCO

Raising Our Vibration: Exploring Higher Consciousness Through Spiritual Practice

Play Episode Listen Later Feb 7, 2023 7:55

You're listening to a podcast from Cancer.Net. This cancer information website is produced by the American Society of Clinical Oncology, known as ASCO, the world's leading professional organization for doctors who care for people with cancer. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Cancer research discussed in this podcast is ongoing, so the data described here may change as research progresses. In this podcast, Cancer.Net Associate Editor Dr. Norah Lynn Henry covers new research in breast cancer treatment, prevention, and survivorship presented at the 2022 San Antonio Breast Cancer Symposium, held December 6-10. Dr. Henry is a Professor and Interim Chief of the University of Michigan's Division of Hematology/Oncology in the Department of Internal Medicine and is the Breast Oncology Disease Lead at the Rogel Cancer Center in Ann Arbor, Michigan. View Dr. Henry's disclosures at Cancer.Net. Dr. Henry: Hi, I'm Dr. Lynn Henry, a breast cancer oncologist from the University of Michigan Rogel Cancer Center. Welcome to this quick summary of updates from the 2022 San Antonio Breast Cancer Symposium. I have no conflicts of interest for any of the trials that I will talk about today. First, I'm going to give a very brief overview of the types of breast cancer, and then talk about some research that was presented on both metastatic and early-stage breast cancer. As a reminder, there are multiple kinds of breast cancer. Some breast cancers are called hormone receptor-positive or estrogen receptor-positive and are stimulated to grow by the hormone estrogen. We treat those cancers with anti-estrogen treatments, which block estrogen or lower estrogen levels. We often combine anti-estrogen treatments with other medications to try to make them work even better against the cancer. Other breast cancers are called HER2-positive. These are often more aggressive cancers, but because they have extra copies of HER2, they often respond to treatments that block HER2. Finally, there are breast cancers that don't have hormone receptors or HER2 receptors. These are called triple-negative breast cancer and are also often fairly aggressive cancers. One of the most exciting takeaways from the San Antonio meeting was the promise of new medications on the horizon to treat hormone receptor-positive, HER2-negative metastatic breast cancer. A commonly used treatment for metastatic breast cancer that is hormone receptor-positive and HER2-negative is fulvestrant, which is a type of medicine called “SERD,” or selective estrogen receptor degrader. At the meeting, we heard new data about 2 new SERD medications: elacestrant that was tested in the EMERALD trial and camizestrant that was tested in the SERENA trial, both of which are oral pills instead of injection medications and both of which may work particularly well against tumors that have mutations in the estrogen receptor called ESR1. In addition, we heard about capivasertib, which is an AKT inhibitor that was shown to work well when combined with fulvestrant and had less toxicity than some of the similar drugs that had previously been tested. For treatment of HER2-positive metastatic breast cancer, there are now a lot of medications that have been FDA approved, so some of the questions that clinical trials are now examining are related to what order we should use the medications in when we are treating patients. We heard about 2 studies of the medication trastuzumab deruxtecan, which I'm going to refer to as Enhertu. This drug is a combination of the anti-HER2 antibody trastuzumab plus a chemotherapy drug, and the antibody targets the drug to a cancer like a guided missile. Enhertu is currently routinely used to treat patients with metastatic HER2-positive breast cancer. We heard updated data that showed that when Enhertu was compared head-to-head against trastuzumab emtansine, also known as Kadcyla, patients who were treated with Enhertu were able to stay on the medication for a lot longer compared to patients who were treated with Kadcyla. We also heard that for patients who had already been treated with Kadcyla but it was no longer working, it is reasonable to switch to treatment with Enhertu at that point, because it is still likely to be effective. These studies may help oncologists decide what order to use these newer medications when treating patients with HER2-positive breast cancer. To switch gears a little bit, I'll now talk about another study I found interesting. This one is in the setting of people who are at high risk of developing breast cancer, but who haven't actually been diagnosed with cancer yet. In general, people are recommended to take either tamoxifen or an aromatase inhibitor medication, which is the same as treatment for patients who have been diagnosed with hormone receptor-positive breast cancer. But in this case, it's trying to prevent them from ever getting breast cancer in the first place. However, many people don't take the medications because they are concerned about side effects. A study was therefore performed in Italy that compared the 5-milligram dose of tamoxifen, which is only one-quarter of the full dose, with placebo for 3 years. After 7 years of follow-up, this low dose of tamoxifen, which is being referred to as “babytam,” was shown to reduce the risk of developing breast cancer by about half, which is similar to the effects seen with the full dose of the medication. Plus, there were fewer side effects. This lower dose is likely to be used regularly for prevention of breast cancer based on these findings, although this lower dose of tamoxifen has not yet been tested to see if it is as effective as the full dose of medication for preventing breast cancer recurrence, so it is not routinely recommended for patients who have a diagnosis of breast cancer to receive this lower dose. Finally, I will touch briefly on exciting results from the POSITIVE trial, which is a trial conducted around the world that examined whether it is safe for young women with hormone receptor-positive breast cancer to stop taking anti-hormone therapy to become pregnant. The women on this trial stopped taking endocrine therapy after taking it for about 18 to 30 months, and then spent up to 2 years trying to become pregnant. About three-quarters of the patients had at least 1 pregnancy during that time, and importantly, there was no increased risk of breast cancer recurrence seen in these patients. Once patients were done with their pregnancy, it was recommended that they restart taking endocrine therapy again. There were a lot of other research findings presented that were related to treatment for both early-stage and metastatic breast cancer at this meeting. Importantly, we got glimpses of the many new drugs on the horizon for treatment of breast cancer, including the 3 that I mentioned already. And we eagerly await the results of large, randomized trials so that the drugs that work can be used to care for patients with breast cancer. But for now, that's it for this quick summary of important research from the 2022 San Antonio Breast Cancer Symposium. Stay tuned to Cancer.Net for future updates from upcoming breast cancer conferences. Thank you. ASCO: Thank you, Dr. Henry. You can find more research from recent scientific meetings at www.cancer.net. Cancer.Net Podcasts feature trusted, timely, and compassionate information for people with cancer, survivors, and their families and loved ones. Subscribe wherever you listen to podcasts for expert information and tips on coping with cancer, recaps of the latest research advances, and thoughtful discussions on cancer care. And check out other ASCO Podcasts to hear the latest interviews and insights from thought leaders, innovators, experts, and pioneers in oncology. Cancer.Net is supported by Conquer Cancer, the ASCO Foundation, which funds lifesaving research for every type of cancer, helping people with cancer everywhere. To help fund Cancer.Net and programs like it, donate at CONQUER.ORG/Donate.

The Enlightenment Network in Your Brain: Dawson Church Interview

Play Episode Listen Later Jan 29, 2023 46:50

ROV PODCAST 50 “The Enlightenment Network in Your Brain: Dawson Church Interview” Best-selling Author, Scientist, Visionary and ScholarDawson Church, PhD, is an award-winning science writer with three best-selling books to his credit. The Genie in Your Genes was the first book to demonstrate that emotions drive gene expression. Mind to Matter showed that the brain creates much of what we think of as “objective reality.” Bliss Brain demonstrates that peak mental states rapidly remodel the brain for happiness.Dr. Church did his undergraduate and graduate work at Baylor University, and obtained his doctorate at Holos University under the supervision of Harvard-trained neurosurgeon Norm Shealey, MD, PhD, founder of the American Holistic Medical Association.Dr. Church has conducted dozens of clinical trials and founded the National Institute for Integrative Healthcare to study and implement promising evidence-based psychological and medical techniques. Its largest program, the Veterans Stress Project, has offered free treatment to over 20,000 veterans with PTSD over the past decade.His groundbreaking research has been published in many prestigious scientific journals. Dawson Church is the editor of Energy Psychology: Theory, Research, & Treatment, a peer-reviewed professional journal.He shares how to apply these breakthroughs to health and athletic performance through EFTUniverse.com, one of the most-visited alternative healing sites on the web.View Dr. Church's full Curriculum Vitae and list of scientific papers.Visit the Events page to register for Dr. Church's upcoming workshops.For more information and support for meditation and awareness practices, including the Raising Our Vibration book, ROV Meditation app, and courses, visit: https://raisingourvibration.net

Lymphoma Highlights from the 2022 American Society of Hematology Annual Meeting, with Christopher Flowers, MD

Fast Keto with Ketogenic Girl

Play Episode Listen Later Jan 26, 2023 8:52

ASCO: You're listening to a podcast from Cancer.Net. This cancer information website is produced by the American Society of Clinical Oncology, known as ASCO, the world's leading professional organization for doctors who care for people with cancer. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guests' statements on this podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Cancer research discussed in this podcast is ongoing, so data described here may change as research progresses. In this podcast, Cancer.Net Associate Editor Dr. Christopher Flowers covers new research in non-Hodgkin lymphoma presented at the 2022 American Society of Hematology Annual Meeting, held December 10-13 in New Orleans, Louisiana. Dr. Flowers is the Chair of the Department of Lymphoma/Myeloma at The University of Texas MD Anderson Cancer Center and was appointed Division Head ad interim of Cancer Medicine in August 2020. View Dr. Flowers' disclosures at Cancer.Net. Dr. Flowers: Hello and welcome to this Cancer.Net podcast. I'm Dr. Christopher Flowers, professor and chair of the Department of Lymphoma and Myeloma at the University of Texas MD Anderson Cancer Center. And it's my great pleasure to talk to you today about updates in lymphoma from this year's American Society of Hematology meeting in December of 2022. I have a number of disclosures related to my work as a consultant for companies in the development of therapies for lymphoma. I will not talk about agents specifically related to those companies, but 2 companies that overlap with some of the areas that I'll talk about in bispecific antibodies includes Genentech, Roche, and Genmab, as well as research support from those companies for research that is performed at MD Anderson. So this year's American Society of Hematology meeting had a number of highlights. I was very fortunate to be the introducer for one of those key highlights, and that was the abstract presented at this year's plenary session. This was actually the first abstract presented in the plenary session where I introduced the abstract and set the context, and Dr. Martin Dreyling from the German group described the TRIANGLE study. So the TRIANGLE study was a randomized controlled clinical trial, meaning that the trial was performed in a randomized fashion to be able to test 3 particular strategies for patients with mantle cell lymphoma. Mantle cell lymphoma, as many of you may know, is a relatively uncommon form of non-Hodgkin lymphoma. It's a kind of lymphoma that can be quite aggressive, and particularly for younger patients who are suitable for aggressive therapy, the role of autologous stem cell transplantation has been something that's been important for the first-line therapy for mantle cell lymphoma. This study evaluated the use of a standard regimen of giving R-CHOP chemotherapy alternating with R-DHAP chemotherapy. So a chemotherapy regimen that includes Ara-C as their component followed by autologous stem cell transplantation. And it compared using that same regimen to giving it with ibrutinib added to the R-CHOP portion of the chemotherapy, followed by ibrutinib maintenance after the stem cell transplant or another experimental arm that added ibrutinib to the R-CHOP portion of the chemotherapy and gave 2 years of ibrutinib maintenance without stem cell transplantation. I think, importantly, this arm compared to each of those 2 experimental arms versus the standard of care and showed graphically that both of the arms that contained ibrutinib, the BTK inhibitor, looked to have improved failure-free survival compared to the standard stem cell transplant arm. Formal statistical tests were performed to compare the arm that included transplant plus ibrutinib showing that that was superior to transplant alone. And it remains to be seen whether that arm is superior to the arm that used ibrutinib alone. But those 2 arms look fairly similar in terms of their outcomes, and also the toxicity associated with the transplant obviously was substantially more than performing the therapy without transplant. This suggested perhaps autologous stem cell transplantation can be removed from frontline therapy for patients with aggressive mantle cell lymphoma and provides provocative data that may help to change practice, both in Europe and in the United States, as well as the rest of the world. A few other abstracts that were presented at this year's ASH meeting presented provocative data about ways to be able to improve the ways that we predict outcomes for patients. Matt Maurer presented the results of the Follicular Lymphoma International Prognostic Index 24, or the FLIPI24, as a risk factor to try and predict patients who might have early progression of disease with follicular lymphoma. One of the things that we know is that when you look at patients with follicular lymphoma, those patients who have progression of their disease within 24 months of the start of chemoimmunotherapy are patients that have markedly worse outcomes. And Dr. Maurer and our colleagues led an international study showing that a new prognostic factor model that included age, hemoglobin, white blood cell count, normalized lactate dehydrogenase, and beta-2-microglobulin, so all laboratory values that are connected within routine clinical practice, along with age, were a better predictor of this early progression of disease. This may serve as a useful model moving forward to help patients and their providers to understand who are the patients who are at higher risk of having aggressive behaving follicular lymphoma, and eventually, we can make strategies that help to address that for those patients. A second provocative model for using integrated genomics helps to identify patients who also have early progression of disease, and those are for patients with diffuse large B-cell lymphoma. This was presented by Kirsten Wenzel from the Mayo group, where Anne Novak was the senior author for this publication. What they did was they integrated the genomics into the clinical prognostic factors and found that there was a particular RNA-seq profile that helped to identify those patients who had early progression of disease with diffuse large B-cell lymphoma. They compared this approach to other prognostic models and suggested that these approaches may be able to improve upon the prediction of outcomes and be incorporated into the ways that we predict treatment strategies for patients with diffuse large B-cell lymphoma in the future. While these are still early on in their development, I think this holds promise for the future management of patients. And then the other class of agents that I'll mention from this year's ASH meeting are the bispecific antibodies. There were several abstracts that addressed this, both in patients with relapsing, refractory, diffuse large B-cell lymphoma, and in patient populations with relapsing refractory follicular lymphoma. One of those highlighted came from Nancy Bartlett, who discussed the role of a specific bispecific antibody for patients with relapsed follicular lymphoma. And I think these agents hold broad promise. So I appreciate your time and attention and hope you enjoyed this podcast and look forward to talking to you in the future about new developments in lymphomas broadly. ASCO: Thank you, Dr. Flowers. You can find more research from recent scientific meetings at www.cancer.net. Cancer.Net Podcasts feature trusted, timely, and compassionate information for people with cancer, survivors, and their families and loved ones. Subscribe wherever you listen to podcasts for expert information and tips on coping with cancer, recaps of the latest research advances, and thoughtful discussions on cancer care. And check out other ASCO Podcasts to hear the latest interviews and insights from thought leaders, innovators, experts, and pioneers in oncology. Cancer.Net is supported by Conquer Cancer, the ASCO Foundation, which funds lifesaving research for every type of cancer, helping people with cancer everywhere. To help fund Cancer.Net and programs like it, donate at CONQUER.ORG/Donate.

Brain Energy: Keto For Metabolic & Mental Health with Dr. Chris Palmer: Part 2

Play Episode Listen Later Nov 21, 2022 63:30

Hi friends! Today's episode is Part 2 of 2 with Dr. Chris Palmer. A Harvard psychiatrist conducting neuroscience for 25 years, Dr. Palmer outlines a revolutionary new understanding that for the first time unites our existing knowledge about mental illness within a single framework: Mental disorders are metabolic disorders of the brain. He explains this new understanding of mental illness in detail, from symptoms and risk factors to what is happening in brain cells. We discuss ketogenic diets, and cutting edge new science regarding the mitochondria. We also discuss the link between metabolism and every factor known to play a role in mental health, including genetics, inflammation, hormones, neurotransmitters, sleep, stress, and trauma. In his new book, Brain Energy, Dr. Palmer sheds light on the new treatment pathways this theory opens up—which apply to all mental disorders, including anxiety, depression, ADHD, alcoholism, eating disorders, bipolar disorder, autism, and even schizophrenia. Brain Energy pairs cutting-edge science with practical advice and strategies to help people reclaim their mental health. View Dr. Palmer's Website Here Black Friday Special! I have never had a sale before! Use the code BLACKFRIDAY for FREE SHIPPING this week only! Click HERE to get the discount automatically applied! Try the new revolutionary new wellness device, the Tone! Test Your Ketones & Fat Burning with your breath! SHIPPING Worldwide!! Order the TONE HERE and Use the code BLACKFRIDAY for FREE SHIPPING this week only! Follow @ketogenicgirl & @optimalproteinpodcast on Instagram to see visuals and posts mentioned on this podcast. Link to join the facebook group for the podcast: https://www.facebook.com/groups/2017506024952802/ Follow Vanessa on instagram to see her meals, recipes, informative posts and much more! Click here @ketogenicgirl Try the Higher Protein Keto Meal Plans & Coaching: https://www.ketogenicgirl.com Special thank you to our podcast sponsor: Magnesium Breakthrough by BiOptimizers BiOptimizers are having an incredible Black Friday special offer from November 21st to 29th. You can get - not only Magnesium Breakthrough - but all of BiOptimizers best in class products with 25% off. BiOptimizers only offers this discount once a year, so don't miss out. Just go to www.bioptimizers.com/fastketo and enter code FASTKETO to get 25% off any order. This is the best time to stock up the products you love and try new ones! All BiOptimizers supplements are best in class. If for some reason you feel differently, you can get a full refund, no questions asked. They are so confident that they offer 365 day money back guarantee! Hey, if you arrived here late and did miss this special offer, don't worry, there is always a 10% off for my listeners with the code FASTKETO But if you arrived just in time, again, the link to go to for the exclusive Black Friday offer starting November 21st is www.bioptimizers.com/fastketo with code FASTKETO Do it while supplies last and don't miss the November 29th deadline. - Prior to beginning a new diet you should undergo a health screening with your physician to confirm that a new diet is suitable for you and to out any conditions and contraindications that may pose risks or are incompatible with a new diet, including by way of example: conditions affecting the kidneys, liver or pancreas; muscular dystrophy; pregnancy; breast-feeding; being underweight; eating disorders; any health condition that requires a special diet [other conditions or contraindications]; hypoglycemia; or type 1 diabetes. A new diet may or may not be appropriate if you have type 2 diabetes, so you must consult with your physician if you have this condition. Anyone under the age of 18 should consult with their physician and their parents or legal guardian before beginning such a diet. Use of Ketogenic Girl videos are subject to the Ketogenicgirl.com Terms of Use and Medical Disclaimer. All rights reserved. If you do not agree with these terms, do not listen to, or view any Ketogenic Girl podcasts or videos.

Brain Energy: Keto For Metabolic & Mental Health with Dr. Chris Palmer: Part 1

Fast Keto with Ketogenic Girl

Play Episode Listen Later Nov 15, 2022 64:22

Hi friends! Today's episode is Part 1 of 2 with Dr. Chris Palmer. A Harvard psychiatrist conducting neuroscience for 25 years, Dr. Palmer outlines a revolutionary new understanding that for the first time unites our existing knowledge about mental illness within a single framework: Mental disorders are metabolic disorders of the brain. He explains this new understanding of mental illness in detail, from symptoms and risk factors to what is happening in brain cells. We discuss ketogenic diets, and cutting edge new science regarding the mitochondria. We also discuss the link between metabolism and every factor known to play a role in mental health, including genetics, inflammation, hormones, neurotransmitters, sleep, stress, and trauma. In his new book, Brain Energy, Dr. Palmer sheds light on the new treatment pathways this theory opens up—which apply to all mental disorders, including anxiety, depression, ADHD, alcoholism, eating disorders, bipolar disorder, autism, and even schizophrenia. Brain Energy pairs cutting-edge science with practical advice and strategies to help people reclaim their mental health. View Dr. Palmer's Website Here Try the new revolutionary new wellness device, the Tone! Test Your Ketones & Fat Burning with your breath! SHIPPING Worldwide!! Order the TONE HERE Follow @optimalproteinpodcast on Instagram to see visuals and posts mentioned on this podcast. Link to join the facebook group for the podcast: https://www.facebook.com/groups/2017506024952802/ Follow Vanessa on instagram to see her meals, recipes, informative posts and much more! Click here @ketogenicgirl Try the Higher Protein Keto Meal Plans & Coaching: https://www.ketogenicgirl.com Special thank you to our podcast sponsor: Magnesium Breakthrough by BiOptimizers Right now you can try BiOptimizers, magnesium breakthrough and any other BiOptimizers product for 10% off, just go to magbreakthrough.com/fastketo and use the code FAST KETO. - Prior to beginning a new diet you should undergo a health screening with your physician to confirm that a new diet is suitable for you and to out any conditions and contraindications that may pose risks or are incompatible with a new diet, including by way of example: conditions affecting the kidneys, liver or pancreas; muscular dystrophy; pregnancy; breast-feeding; being underweight; eating disorders; any health condition that requires a special diet [other conditions or contraindications]; hypoglycemia; or type 1 diabetes. A new diet may or may not be appropriate if you have type 2 diabetes, so you must consult with your physician if you have this condition. Anyone under the age of 18 should consult with their physician and their parents or legal guardian before beginning such a diet. Use of Ketogenic Girl videos are subject to the Ketogenicgirl.com Terms of Use and Medical Disclaimer. All rights reserved. If you do not agree with these terms, do not listen to, or view any Ketogenic Girl podcasts or videos.

A New View / Dr. Sabrina Sessions / Bro. Marshall Perot

Miracle Internet Church Radio

Play Episode Listen Later Nov 4, 2022 192:00

Galatians 4:6-7 King James Version 6 And because ye are sons, God hath sent forth the Spirit of his Son into your hearts, crying, Abba, Father. 7 Wherefore thou art no more a servant, but a son; and if a son, then an heir of God through Christ

god jesus christ father spirit loved galatians precious abba redeemed adopted new view perot view dr

What's Wrong With The Cannabis Industry? with Dr. Ethan Russo, Founder of Credo Science

The Cannabis Conversation | Medical Cannabis | CBD | Hemp

Play Episode Listen Later Oct 19, 2022 44:07

What's wrong with the cannabis industry?Joining us again on the latest episode of The Cannabis Conversation is Dr Ethan Russo, Founder of Credo Science - a novel medical science company.We discuss the prejudice and ignorance against Cannabis, as well as safety monitoring, legalisation and some of the challenges the industry is facing, including a lack of proper funded research in the area.The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing.Get in touch at www.luminorecruit.com/About Ethan RussoEthan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and Founder/CEO of CReDO Science https://credo-science.com He is also Medical Director of Andira Pharmaceuticals Andira – Bringing Healing to Life and Senior Medical Advisor to Canurta Home | CanurtaPreviously he was Director of Research and Development for the International Cannabis and Cannabinoids Institute, 2017-19, Medical Director of PHYTECS, 2015-2017, and from 2003-2014, Senior Medical Advisor, medical monitor/study physician to GW Pharmaceuticals for numerous Phase I-III clinical trials of Sativex® and Epidiolex®.He was a clinical neurologist in Missoula, Montana for 20 years. He has held faculty appointments in Pharmaceutical Sciences at the University of Montana, and in Medicine at the University of Washington. He is author/editor of seven books and has published more than 50 peer-reviewed articles.ResourcesJoin Dr. Russo on LinkedIn: https://www.linkedin.com/in/ethan-russo-md-468b19a/View Dr. Russo's clinical research papers: https://www.researchgate.net/profile/Ethan_RussoCReDO Science Website: https://credo-science.com/

Dr. Mary Dana Hinton - Paving the Pathways to Higher Education with Access and Inclusion

Rebuilding The American Dream

Play Episode Play 50 sec Highlight Listen Later Sep 7, 2022 37:18

In a truly inspirational discussion, Dr. Mary Dana Hinton, President of Hollins University shares her deep and abiding commitment to educational access, equity, and the education of women. Reflecting on her own experiences, Dr. Hinton envisions, and strives for, a truly inclusive and equitable growth experience for those at Hollins.View Dr. Hinton's TEDx talk "Leading from the Margins" here: https://www.ted.com/talks/mary_dana_hinton_leading_from_the_marginsDr. Hinton earned a Ph.D. in religion and religious education with high honors from Fordham University, a Master of Arts degree in clinical child psychology from the University of Kansas, Lawrence, and a Bachelor of Arts degree in psychology from Williams College. She also holds two honorary Doctor of Humane Letters degrees from Misericordia University and the Massachusetts College of Liberal Arts.

Naturopathic and Complementary Medicine: What is it?

winters naturopathic complementary medicine nasha winters chadi view dr

Play Episode Listen Later Aug 30, 2022 76:29

To explain and dissect the world of naturopathic medicine, Chadi hosts Nasha Winters, ND, FABNO, a renowned speaker and author on the topic. Dr. Winters shares her background of a devastating, terminal ovarian cancer diagnosis 30 years ago, the nontraditional care she received that put her on the road to recovery, and how that set things in motion for her career. Then, Dr. Winters expands on a system she has developed to understand the tumor “terrain” rather than the tumor itself, patient cases she's dealt with and how integrative treatment approaches have been very powerful, the type of training she received to become qualified to consult and treat patients, and the ins-and-out of the curriculum for this training, among other things. View Dr. Winters' website. https://www.drnasha.com/ Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on Youtube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA

Can Urologists Spearhead Medical Oncology Research?

gu shore urologists spearhead enact medical oncology chadi view dr jama oncology oncology research

Play Episode Listen Later Jul 26, 2022 55:16

Chadi hosts Dr. Neal Shore, a urologic oncologist who became heavily involved in GU oncology research – including trials that incorporate systemic chemotherapy. Dr. Shore has a unique practice where he and his staff deliver chemotherapy when appropriate. Chadi was intrigued by this setting as medical oncologists are the ones customarily delivering chemotherapy, and invited him to the show to share how this all started, its pros and cons, and the impact on patients. Dr. Shore explains how the field has seen drastic changes since the early 1990's, why he decided to spearhead bringing clinical research into his community clinic, and how his clinic is staffed and structured to support a functioning and successful research hub. Then, the discussion pivots to his recently published clinical trial, ENACT, and the controversy surrounding use of enzalutamide monotherapy in low- or intermediate-risk prostate cancer. There's been so much controversy and backlash about the ENACT trial that Chadi had to ask him about it and his reaction to what happened when the article was published. View Dr. Shore's recently published ENACT study in JAMA Oncology. https://jamanetwork.com/journals/jamaoncology/fullarticle/2793567 Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on Youtube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA

Pharmacovigilance and Adherence to Oral Oncolytics

action journal fda oral emory university pharmd asco adherence clinical oncology fccp donald harvey jco chadi winship cancer institute pharmacovigilance view dr bcop

Play Episode Listen Later Jul 5, 2022 55:13

Joining Chadi on today's show is Donald Harvey, PharmD, BCOP, FCCP, FHOPA, Winship Cancer Institute of Emory University. Dr. Harvey shares available career paths and how the pharmacist role has evolved over the years, how pharmacists continue to stay involved with patients after discharge, strategies he uses to help cancer patients adhere to oral oncolytics, and his “Call to Action” to improve such adherence – as co-planned by the FDA and ASCO and published in Journal of Clinical Oncology. The discussion is very detailed and enlightening; you won't want to miss it! View Dr. Harvey's publication “Call to Action for Improving Oral Anticancer Agent Adherence.” https://ascopubs.org/doi/10.1200/JCO.21.02529 Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on Youtube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA

#38: Safety and Human Factors in Healthcare with Terry Fairbanks of MedStar Health

Naturalistic Decision Making

Play Episode Listen Later Jul 1, 2022 48:16

Rollin J. “Terry” Fairbanks, MD, MS, is the Vice President Quality and Safety at MedStar Health, Professor of Emergency Medicine at Georgetown University, and Founding Director of the National Center for Human Factors in Healthcare. A board-certified emergency physician, he practices in the MedStar Washington Hospital Center emergency department. Dr. Fairbanks also holds an academic appointment as adjunct associate professor of Industrial Systems Engineering at the University at Buffalo. He earned a bachelors degree in mathematics and physics and a masters degree in industrial systems engineering/human factors engineering, and after medical school he completed specialty training in emergency medicine, the HRET/NPSF Patient Safety Leadership Fellowship, and Wharton's Physician Leadership Certificate Program at MedStar Health. Trained in safety science prior to entering the medical field, Dr. Fairbanks is also a former paramedic, EMS medical director, and general aviation pilot, he is known for inspiring people to think differently about healthcare's approach to quality, safety, and risk. As a member of the MedStar Health Leadership Team, he is responsible for system-wide quality and safety. Dr. Fairbanks has contributed more than 120 publications to the healthcare quality and safety, human factors engineering and medical literature, and co-edited a book on cognitive systems engineering in healthcare. Dr. Fairbanks has served in many national and international roles, including the National Patient Safety Foundation Board of Advisors, the POLITICO Health IT Advisory Forum, AHRQ Patient Safety Network Technical Expert Advisory Panel, and he is a Health Research and Educational Trust (HRET) Senior Fellow. He has served in advisory roles for the Office of the National Coordinator for Health IT, Pew Charitable Trusts, the American Medical Association, and has held formal consultative roles with the US, Australian, British, and Spanish governments. In 2017, he was listed by Becker's Hospital Review in Top 50 Experts Leading the Field of Patient Safety. View Dr. Fairbanks' publications on PubMed View Dr. Fairbanks' Complete Bibliography Learn more about NDM: NaturalisticDecisionMaking.org Journal of Cognitive Engineering and Decision Making Where to find the hosts: Brian Moon Brian's website Brian's LinkedIn Brian's Twitter Laura Militello Laura's website Laura's LinkedIn Laura's Twitter

Ep. 40 | We're talking triage with Shadi Ireifej from VetTriage

#IVETSOHARD, Technology And Workflows For Veterinary Teams

Play Episode Listen Later Jun 17, 2022 23:33 Transcription Available

In This Episode:Dr. Stacee and Dr. Caitlin chat with Dr. Shadi Ireifej from VetTriage about how using technology can help you see more patients in a day and help offload some of the workload from your staff.Listen in to get some great tips you can implement in your practice today! More Shadi Ireifej from VetTriage:Shadi J. Ireifej DVM DACVS graduated from the State University of New York at Binghamton where he received his Bachelor of Science degree in Biology (2001, Magna cum laude). He then attended Cornell University where he received his Doctor of Veterinary Medicine degree (2006, DVM).In 2020, Dr. Ireifej changed gears in his already illustrious career, finding a novel and state-of-the-art means of reaching concerned pet owners and their ill pets worldwide, VetTriage. Dr. Ireifej currently serves as their Chief Medical Officer.Shadi has been published in scientific and medical journals and enjoys lecturing to a variety of audiences. He is known for being a positive force and energetic force, both professionally and personally.View Dr. Shadi's full bio HEREEpisode WebsiteSubscribe & Review On Apple Podcasts:Thanks for being an IVSH listener! We hope this podcast has been inspiring and has helped you learn a few new tricks when it comes to technology and workflows that really work.To help get this podcast in front of more veterinary professionals and teams, please consider subscribing to the podcast on Apple and leaving a review.Sign up for #IVETSOHARD Resources Email List (below) to get the 5 takeaways from this episode in PDF form.Click Here to subscribe and review #IVETSOHARD on Apple Podcasts! About our sponsorVet2Pet is veterinary medicine's only customizable, all-in-one client connection platform. Built for veterinary teams by veterinary pros, the Vet2Pet custom-branded hospital app and practice dashboard have been proven to decrease phone time by an average of 3 hours per day, increase pharmacy engagement by up to 68%, and increase client spending by up to 41%. Visit the Vet2Pet website to learn more. Subscribe to Bits & Bytes, Vet2Pet's newsletter that was recently called “the best newsletter in vet med” by an industry leader.Sign up for a demo to find out how Vet2Pet can help your practice.

Starving the Soul... Metaphorically Speaking with Dr. Anita Johnston, PH.D., CEDS-S

Recovery Bites with Karin Lewis

Play Episode Listen Later Jun 6, 2022 48:27

In this episode, Karin welcomes Dr. Anita Johnston, Ph.D., CEDS-S, clinical psychologist, certified eating disorders specialist and supervisor, author of "Eating in the Light of the Moon: How Women Can Transform Their Relationship with Food Through Myths, Metaphors, and Storytelling," and eating psychology pioneer with a passion for working with eating difficulties for over thirty-five years.Join Karin and Dr. Johnston for a discussion on the transformational power of collective healing practices, what it means to “belong” as opposed to “fitting in,” the use of metaphors from a therapeutic standpoint, shifting one's understanding of triggers, holistically addressing hunger, Anita's best selling novel, “Eating in the Light of the Moon,” and much more!• Learn more about Dr. Johnston• Work with Dr. Johnston• Learn about and purchase a copy of "Eating in the Light of the Moon"• Visit the Light of the Moon Cafe, an online platform for transforming your relationship with food and body offering four self-study courses & group programs• Learn about the ‘Ai Pono Hawaii Eating Disorder Program, Dr. Johnston's holistic eating disorder recovery center and their treatment options• View Dr. Johnston's free resources• Watch “The Log Video”• Follow Dr. Johnston on Facebook and Instagram

soul speaking moon storytelling eating johnston starving metaphors metaphorically ceds anita johnston view dr ceds s moon cafe

A Compassionate Conversation on Suicide with Dr. Katie Gordon

Recovery Bites with Karin Lewis

Play Episode Listen Later May 23, 2022 44:51

In this episode, Karin welcomes Dr. Katie Gordon, a licensed clinical psychologist who specializes in cognitive-behavioral therapy. Join Karin and Dr. Gordon to discuss statistics on suicide, the risk factors for suicide, safety plans for those at risk, compassionately validating the emotional components of suicidal thoughts, skills for clinicians and supporters, and toxic societal messages.Prior to working as a therapist, Dr. Gordon was a professor for ten years. She was recognized as an Inspiring Teacher for her classes about psychopathology, empirically-supported therapy, and cultural diversity. Dr. Gordon is a mental health researcher who has published over eighty scientific articles and book chapters on suicidal behavior, disordered eating, and related topics. She co-hosts Psychodrama Podcast, blogs for Psychology Today, and shares mental health information through her website, kathrynhgordon.com. Dr. Gordon's first book, “The Suicidal Thoughts Workbook”, was published in July of 2021.• Learn more about Dr. Gordon• Discover Dr. Gordon's research and media• View Dr. Gordon's resource page for help and information• Follow Dr. Gordon on Twitter and Instagram• Purchase a copy of "The Suicidal Thoughts Workbook"• Listen to Dr. Gordon's as co-host on the Psychodrama Podcast

conversations suicide compassionate psychology today view dr

Collider Bias: What Is It and Why We Should Care